Cambrex Recognized at 2019 CMO Leadership Awards
Cambrex has received CMO awards for five consecutive years, and this year, has been recognized in the following categories: compatibility, service, expertise, quality and reliability; and were noted for four individual attribute awards for accessible senior management, reputation, right first time, and strength of science.
“Cambrex is once again honored to be recognized as a leading supplier to the pharmaceutical industry,” commented Steven Klosk, President and Chief Executive Officer at Cambrex. He added, “With our recent acquisitions of Halo Pharma and Avista Pharma Solutions, we have created a leading, fully integrated small molecule CDMO across the entire drug life cycle offering more products and services to our customers. Being the recipient of a 2019 Leadership Award is a testament to the hard work of all our employees across the entire company.”
“The value and importance of the Life Science Leader CMO Awards grows each year. No industry awards are more meaningful than these recognizing the highest level of accomplishment as evaluated by actual customers. An award in any of the categories assessed, including capabilities, compatibility, expertise, quality, reliability and service, adds a clear acknowledgement of the leadership provided by the CMO recipient. Our congratulations to all of this year’s CMO Award winners — you keep the industry on the path to further success,” says Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma.
Established in 2011, the CMO Leadership Awards recognize top outsourcing partners, determined by feedback from sponsor companies who outsource manufacturing. The awards are presented by Life Science Leader magazine and Industry Standard Research.
For more information, please visit www.cambrex.com
Tel: +44 7803 443 155
Source: Cambrex Corporation